Shree Ganesh Remedies (NSE:SGRL) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SGRL Shree Ganesh Remedies Ltd NSE:SGRL
71 GF Score
Price ₹501.05
GF Value ₹589.26
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Shree Ganesh Remedies Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NSE:SGRL vs : Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shree Ganesh Remedies's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shree Ganesh Remedies Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shree Ganesh Remedies's Short Interest distribution charts can be found below:

* The bar in red indicates where Shree Ganesh Remedies's Short Interest falls into.


NSE:SGRL
71GF Score
Shree Ganesh Remedies Ltd NSE:SGRL
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shree Ganesh Remedies (NSE:SGRL) Overvalued in 2026?

Based on GuruFocus' analysis, Shree Ganesh Remedies stock appears to be undervalued. The current stock price of ₹501.05 is trading 15% below its estimated GF Value™ of ₹589.26. GuruFocus considers Shree Ganesh Remedies to be Modestly Undervalued.

Key valuation signals for NSE:SGRL:

  • Short Interest:
  • GF Value™: ₹589.26 vs. price of ₹501.05 (15% below fair value)
  • GF Score™: 71/100 with 4 warning signs

No single metric tells the full story. See the NSE:SGRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shree Ganesh Remedies Business Description

Comparable Companies
Other Exchanges 540737:India
Address Plot No. 6002, 6003, 6011 & 6012, GIDC Industrial Estate, Bharuch, Ankleshwar, GJ, IND, 393002
Shree Ganesh Remedies Ltd manufactures drug intermediates, chemicals, and specialty fine chemicals for the pharmaceutical industry. The company offers pharmaceutical and specialty chemical products, including Trityl chloride, Furoyl chloride, and Dinitolmide. The company's business falls under the primary segment of Bulk Drug Intermediaries.
71GF Score

Get the complete analysis for NSE:SGRL

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹501.05
Price
₹589.26
GF Value